Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole as Adjuvant Therapy in AML
NCT07069933Phase 2Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jul 2025
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of itraconazole in acute myeloid leukemia (AML), sponsored by Mansoura University. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
itraconazole
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT07069933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07069933.